Short Interest in AB Science S.A. (OTCMKTS:ABSCF) Drops By 35.0%

AB Science S.A. (OTCMKTS:ABSCF) was the target of a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 21,900 shares, a drop of 35.0% from the June 15th total of 33,700 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

AB Science Price Performance

ABSCF opened at $2.70 on Friday. AB Science has a fifty-two week low of $2.55 and a fifty-two week high of $3.84. The stock has a fifty day moving average of $2.70 and a 200-day moving average of $3.33.

AB Science Company Profile

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.